MétaCan
Menu
← Retour à la cohorte
Enregistrement W2942114051 · doi:10.1097/01.ju.0000555586.05782.19

MP22-02 GNRH ANTAGONISTS HAVE DIRECT INHIBITORY EFFECTS ON CASTRATION-RESISTANT PROSTATE CANCER VIA INTRACRINE ANDROGEN AND AR-V7 EXPRESSION

2019· article· en· W2942114051 sur OpenAlexaboutno aff
Vito Cucchiara, Joy C. Yang, Chengfei Liu, Hans Adomat, Emma S. Tomlinson Guns, Martin Gleave, Allen C. Gao, Christopher P. Evans

Notice bibliographique

RevueThe Journal of Urology · 2019
Typearticle
Langueen
DomaineMedicine
ThématiqueProstate Cancer Treatment and Research
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésIntracrineProstate cancerMedicineTestosterone (patch)Androgen deprivation therapyAndrogen receptorAndrogenCancerManagement of prostate cancerAgonistInternal medicineCancer researchEndocrinologyReceptorHormoneParacrine signalling

Résumé

récupéré en direct d'OpenAlex

You have accessJournal of UrologyProstate Cancer: Advanced (including Drug Therapy) II (MP22)1 Apr 2019MP22-02 GNRH ANTAGONISTS HAVE DIRECT INHIBITORY EFFECTS ON CASTRATION-RESISTANT PROSTATE CANCER VIA INTRACRINE ANDROGEN AND AR-V7 EXPRESSION Vito Cucchiara*, Joy Yang, Chengfei Liu, Hans Adomat, Emma Guns, Martin Gleave, Allen Gao, and Christopher Evans Vito Cucchiara*Vito Cucchiara* More articles by this author , Joy YangJoy Yang More articles by this author , Chengfei LiuChengfei Liu More articles by this author , Hans AdomatHans Adomat More articles by this author , Emma GunsEmma Guns More articles by this author , Martin GleaveMartin Gleave More articles by this author , Allen GaoAllen Gao More articles by this author , and Christopher EvansChristopher Evans More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555586.05782.19AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Hormone therapy is currently the mainstay in the management of locally advanced and metastatic prostate cancer (PCa). Degarelix (Firmagon, Deg), a GnRH receptor antagonist demonstrated some advantages over the LHRH agonist Leuprolide (Leup) by avoiding “testosterone flare” and lower FSH levels. We compared the effect of Deg and Leup on prostate cancer (PC) cell progression in vitro and in vivo. METHODS: RT-qPCR was conducted for GnRH type 2 receptor in PC cell lines. PSA-Luc assays were performed coupled with or without AR-V7 transfection in C4-2B cells. PC cell proliferation in the presence of Leup and Deg was evaluated by cell counts. Western blotting analysis and RT-qPCR were performed to examine the levels of AR-FL and AR variants (V7) upon treatments with Leup and Deg alone or in combination with antiandrogens (abiraterone acetate, AA or enzalutamide, Enza). In vivo VCaP xenographs were treated with control, castration, Leup or Deg in a 6-week period of time. Tumor progression was monitored by biweekly calliper measurement. Harvested tumors were stained for Ki67 and subjected to steroid measurement by LC-MS. RESULTS: GnRHR2 was readily detectable in PC cells. AR transcriptional activity reported by PSA-Luc assay was modulated by both Leup and Deg. In LNCaP and C4-2B MDVR cells, 20µM Deg significantly reduced the cell viability (p<0.01). GnRH-antagonist (alone or in combination with AA or Enza) counteracted the transactivation activity of AR by reducing AR-FL and AR variants at the protein level. In C4-2BMDVR cells, Deg reduced AR-V7 protein expression by 26 to 40% alone or combined with AA and Enza compared to control. Leup, however, enhanced variant expression. Deg reduced AR-variant levels from 17 to 41% in monotherapy or combinations compared to control. In mice, Leup slightly suppressed tumor growth compared to controls (p>0.05). However, tumors in Deg-treated group were 1.5-fold smaller than Leup-treated group but 1.7-fold bigger than surgical castration-group. Ki67 IHC staining confirmed the difference in tumor proliferation among groups. Measurements of intratumoral steroids by LC-MS from tumors, serum samples or cell pellets confirmed that Deg decreased the levels of testosterone and steroidogenesis pathway intermediates, comparable to surgical castration; while Leup had no inhibitory effect. CONCLUSIONS: Our results suggest a selective mechanism of action of Deg against AR-variants. The present study provides additional molecular insights regarding the mechanism of Deg compared to GnRH agonist therapy which may have clinical implications. Source of Funding: Ferring Sacramento, CA; Vancouver, Canada; Sacramento, CA© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e316-e317 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Vito Cucchiara* More articles by this author Joy Yang More articles by this author Chengfei Liu More articles by this author Hans Adomat More articles by this author Emma Guns More articles by this author Martin Gleave More articles by this author Allen Gao More articles by this author Christopher Evans More articles by this author Expand All Advertisement PDF downloadLoading ...

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Expérimental (laboratoire) · Signal consensuel: Expérimental (laboratoire)
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,051
Score d'incertitude au seuil0,171

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0010,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,001
Charge utile insuffisante (le modèle a refusé de juger)0,0510,009

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,010
Tête enseignante GPT0,291
Écart entre enseignants0,281 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeExpérimental (laboratoire)
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2019
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueThe Journal of Urology→Même sujetProstate Cancer Treatment and Research→Travaux en français237 207→